MassBio

1 week to go until our #PatientAdvocacySummit26! Wherever you sit in biopharma, from patient advocacy to C-suite to research scientist, the stories you'll hear on 11/12 will remind all of us in life sciences why our work matters. Free for MassBio Members: massbio.org/events/patient…

"There's a true cost in human life to the delays in getting drugs approved."

That urgency ran through every room on Oct. 15 at #AlignSummit26.

For more video, visit #MBVision - mbvision.massbio.org/Channel/Though…

Treasury’s proposed rule adding biotech to the COINS outbound investment regime is a major moment for our industry, and MassBio is in the conversation. Thanks to @WSJ Pro’s Brian Gormley for including our perspective: wsj.com/pro/venture-ca…

Months into an AI rollout, the scientists and clinicians it was built for are still working around it. Sound familiar?
Read this new guest perspective from Craig Wylie of @adlittle - one of our partners at R&D Reimagined on 11/2: massbio.org/news/recent-ne…

Our #MassBioMembers came out to celebrate Oktoberfest last night.🥨Thank you for attending and making it a great event!

📸 View event photos: flic.kr/s/aHBqjD8iFQ

Missed this one? Join us at an upcoming member event: massbio.org/events/